The Biscayne Neurotherapeutics brand, founded in 2011 (United States), from 1 sister brand and 4958 competing brands. Biscayne Neurotherapeutics is owned by Supernus Pharmaceuticals, listed on the stock exchange of New York Biscayne Neurotherapeutics is part of the Drug Manufacturers activity sector.
Share price and profitability of the share Supernus Pharmaceuticals (Biscayne Neurotherapeutics)
Buy Supernus Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Supernus Pharmaceuticals
(Biscayne Neurotherapeutics)
over 5 years*
USD 22.63
Stock market history Supernus Pharmaceuticals (Biscayne Neurotherapeutics)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
